Linear Clinical Research Current Trials Menu

LE180706 | DMTS Study

Recruiting Now

Help us trial a new investigational treatment designed to be used in the management of post-operative pain. Dexmedetomidine is a sedative drug currently approved in Australia by the Therapeutic Goods Administration (TGA) for intravenous use. It is used in hospital settings to sedate patients prior to and during surgical procedures. We are investigating a transdermal drug delivery system (skin patch) to be used as an alternative to intravenous dosing to reduce post-operative pain.

You Get $2140! 

APPLY NOW

Visit Schedule

One in-house stay of 7 nights and 8 days

CohortIn-House Period 
Check-in D -1Check-out D7
510-Apr 17-Apr

General volunteer informationVolunteer FAQsRefer a FriendSpeak to us on the Phone

APPLY NOW

Inclusion Criteria

  • Healthy Males and Females
  • Between 18 – 60 years of age
  • Body Mass Index (BMI) must be between 18.0 – 38.0 kg/m2 
  • Must be non-smokers (Max 2 cigarettes per month within the previous 6 months)
  • Must not have any existing chronic skin conditions (e.g. psoriasis, eczema, acne, rosacea), skin allergies, or sensitivities that could prevent the ability to wear a transdermal patch.
  • Must not have any scars, tattoos, burns, wounds, or excessive hair on the upper portion of the arm.
  • Must not have any clinically significant illness, disease, or severe allergies.
  • Must have a resting heart rate greater than 60 BPM

Find out now if you’re eligible by answering our pre-screening questions below.